Vancouver biotech NanoVation Therapeutics has announced a multi-year partnership with Novo Nordisk to advance the development of novel genetic medicines targeting cardiometabolic and rare diseases. With the partnership, NanoVation will receive research funding and is eligible to receive up to approximately USD $600 million in up-front cash and potential milestone payments, as well as tiered […]
Nanovation Therapeutics
Innovate BC Awards $2.3 Million to B.C. R&D Projects
Last week at an awards ceremony in Vancouver, Innovate BC awarded $2,325,000 to eight B.C. research and development projects that are creating game-changing innovations that are improving lives for British Columbians. Specifically, this year’s funding, through Innovate BC’s Ignite program, is accelerating the commercialization of biotech, cleantech, mining, agriculture, and forestry projects. “Innovation in is […]